Dialysis patients' symptoms often ignored – new trial aims to change that

NCT ID NCT06257134

Symptom relief Sponsor: Central Hospital, Nancy, France Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether having dialysis patients report their symptoms every month – and automatically alerting their care team when symptoms are severe – can improve their quality of life. About 2,293 adults with end-stage kidney disease on dialysis will take part across French centers. Half will get usual care, and half will have their symptom scores sent to staff so they can act quickly. The goal is to see if this simple monitoring helps patients feel better physically and mentally over 18 months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance: systematic symptom monitoring with feedback to healthcare teams
What this could lead to: If it works, this could give dialysis patients a better quality of life by helping doctors catch and treat symptoms sooner.
What could go wrong: This is a large trial, but it's testing a monitoring process, not a new drug. The benefit may be small or hard to measure, and results may not apply to all dialysis centers.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 2,293 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2026

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Symptom collection phase The inclusion criteria for patients are as follows: * Individuals who have received full information on the organization of the research and who have not objected to their participation and to the use of their data. * Adults aged 18 and over * Patients with end-stage renal disease treated by dialysis in participating dialysis units * Patients able to answer questionnaires Process evaluation phase The inclusion criteria for healthcare professionals are as follows: * Individuals who have received full information on the organization of the research and who have not objected to their participation and to the use of their data. * Patients with end-stage renal disease treated by dialysis in participating dialysis units. * Doctors and nurses working in the dialysis unit taking part in the study. Exclusion Criteria: The non-inclusion criteria for patients are as follows: * Minors * Patients under legal protection, guardianship or curatorship * Patient not communicating or unable to give consent * Patient not being treated in a dialysis unit participating in the study * Patients being treated temporarily in a participating dialysis unit (respite care, vacationers, etc.) * Patient with cognitive disorders * Patient unable or unwilling to answer questionnaires The non-inclusion criteria for healthcare professionals are as follows: * Non-voluntary healthcare professional * Healthcare professional not working in the participating facility

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for End-stage renal disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

chronic kidney disease end stage renal failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

End-stage renal disease

How to take part

Only the study team decides who joins. These are the ways to reach them.

The places running it

3 sites. The list below names each one and where it is.
The official record

ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

Open the record ↗
A doctor treating you

A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Dialysis patients' symptoms often ignored – new trial aims to change that

What the study statuses mean